Michael Harsh

This profile gathers the share dealings of Michael Harsh across 2 companies, led by ENDRA Life Sciences Inc. and Compute Health Acquisition Corp. In total, 3 filings cover trades dated from 1 August 2023 to 21 January 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 23 January 2026 came the latest disclosure, a share grant in ENDRA Life Sciences Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.